Tag: Anvisa

• Wednesday, August 19th 2020 - 09:58 UTC

  Brazil approved human clinical trials for a potential Johnson & Johnson Covid-19 vaccine

  

  Brazil approved on Tuesday human clinical trials for a potential COVID-19 vaccine developed by Johnson & Johnson, the fourth candidate to trial in the Latin American country that has become key to the global race for a vaccine.

• Wednesday, December 4th 2019 - 09:47 UTC

  Brazil approves the sale of cannabis-based products for medical use

  

  Brazil's health watchdog on Tuesday approved the sale of cannabis-based products for medical use in pharmacies to people with a prescription. The regulation, which takes effect in the coming months, also allows for the manufacture of such products in a laboratory, the Brazilian Health Regulatory Agency (Anvisa) said in a statement.

• Wednesday, February 27th 2019 - 09:17 UTC

  Brazil says glyphosate is non-cancerous, but health risks remain for those exposed to the weed-killer

  

  Analysts at Brazilian health agency Anvisa have determined that the weed-killer glyphosate does not cause cancer while recommending exposure limits as international pressure to reduce use of the chemical grows. Companies such as Bayer AG and its unit Monsanto, which produces glyphosate-based weed-killers, have faced legal challenges over allegations that glyphosate causes cancer. A new study published this month also links high exposure to cancer.